FRAMINGHAM, Mass.--(BUSINESS WIRE)--Solace Therapeutics, a medical technology company focused on developing breakthrough treatments for urinary incontinence, today announced that it has completed enrollment in the SUCCESS (Stress Urinary inContinence Control Efficacy and Safety Study) Clinical Trial ahead of schedule due to overwhelming patient interest. According to the Company, nearly 105,000 women visited www.stopsui.com to learn about the Vesair Bladder Control procedure and trial eligibili
| < Prev | Next > |
|---|
